 |
20 Diseases |  |
0 Trials |
|
0 Trials |  |
68 News |  |
| «12 |
- faldaprevir (BI201335) / Boehringer Ingelheim, deleobuvir (BI 207127) / Boehringer Ingelheim
New P2 trial, Combination therapy: This Trial Evaluates Safety, Pharmacokinetic Profile and Anti-viral Response of BI 207127 and BI 201335 for Patients With Chronic Hepatitis C (clinicaltrials.gov) - Feb 6, 2012
P2, N=25, Completed, Sponsor: Boehringer Ingelheim Pharmaceuticals
- ||| faldaprevir (BI201335) / Boehringer Ingelheim, deleobuvir (BI 207127) / Boehringer Ingelheim
New P1 trial, Combination therapy: Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected Patients (clinicaltrials.gov) - Feb 1, 2012
P1, N=72, Active, not recruiting, Sponsor: Boehringer Ingelheim